Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911645 · ClinicalTrials.gov registry record · NA
Diagnostic Reasoning With Customized GPT-4 Model
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06911645: Completed NA study, sponsored by Stanford University.
NCT06911645 is a NA study that has completed, run by Stanford University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06911645, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will assess the impact of immediate access to a customized version of GPT-4, a large language model, on performance in case-based diagnostic reasoning tasks. Specifically, it will compare this approach to a two-step process where participants first use traditional diagnostic decision support tools to support their diagnostic reasoning before gaining access to the customized GPT-4 model.
Primary Outcome
The primary outcome will be the percentage of correct responses per case (range: 0 to 100). For each case, participants will be asked to provide their top three differential diagnoses, along with supporting and opposing findings for each. They will receive 1 point for each plausible diagnosis. Supporting and opposing findings will be graded based on correctness, with 1 point for a partially correct response and 2 points for a completely correct response. Participants will then select their top d
Interventions
- OTHER Immediate access to customized version of GPT-4
- OTHER Access to customized version of GPT-4 following use of conventional resources
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2025-01-24 |
| Phase | NA |
What the finished NCT06911645 record still lists
NCT06911645 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Immediate access to customized version of GPT-4 is the first listed.
NCT06911645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06911645 about?
NCT06911645 is a clinical study titled "Diagnostic Reasoning With Customized GPT-4 Model". This study will assess the impact of immediate access to a customized version of GPT-4, a large language model, on performance in case-based diagnostic reasoning tasks. Specifically, it will compare this approach to a two-step process where participants first use traditional diagnostic decision supp...
What is the current status of trial NCT06911645?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-12-16. Estimated completion is 2025-01-24.
What interventions are being tested in trial NCT06911645?
The interventions under investigation include: Immediate access to customized version of GPT-4 (OTHER), Access to customized version of GPT-4 following use of conventional resources (OTHER).
Who is sponsoring clinical trial NCT06911645?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06911645's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI